HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ming-Lun Yeh Selected Research
Ming-Lun Yeh Research Topics
Disease
70
Chronic Hepatitis C
09/2022 - 11/2008
47
Infections
08/2022 - 04/2009
36
Hepatocellular Carcinoma (Hepatoma)
04/2022 - 02/2011
30
Fibrosis (Cirrhosis)
07/2022 - 01/2011
20
Chronic Hepatitis B
02/2022 - 01/2014
18
Hepatitis B
07/2022 - 01/2011
15
Neoplasms (Cancer)
02/2022 - 04/2008
15
Liver Cirrhosis (Hepatic Cirrhosis)
01/2021 - 05/2011
13
Hepatitis C
01/2021 - 01/2013
8
Viremia
12/2021 - 01/2014
7
Hepatitis
07/2022 - 01/2014
7
Liver Diseases (Liver Disease)
11/2018 - 01/2013
5
Non-alcoholic Fatty Liver Disease
03/2022 - 03/2016
5
Fatty Liver
12/2021 - 07/2015
4
Chronic Renal Insufficiency
02/2022 - 04/2021
4
Disease Progression
01/2022 - 06/2017
3
Body Weight (Weight, Body)
07/2022 - 05/2015
3
Hypertension (High Blood Pressure)
01/2022 - 01/2020
3
Diabetes Mellitus
01/2022 - 07/2016
3
Coinfection
10/2021 - 01/2018
3
HIV Infections (HIV Infection)
10/2016 - 01/2014
2
Virus Diseases (Viral Diseases)
02/2022 - 09/2016
2
Hyperlipidemias (Hyperlipidemia)
01/2022 - 01/2021
2
Cryoglobulinemia
01/2022 - 11/2018
2
Chronic Kidney Failure (Chronic Renal Failure)
08/2021 - 01/2021
2
Reinfection
01/2021 - 01/2013
2
Hyperuricemia
03/2020 - 01/2018
2
Liver Failure
01/2020 - 01/2018
2
Insulin Resistance
05/2015 - 09/2011
2
Liver Neoplasms (Liver Cancer)
02/2015 - 07/2013
2
Wounds and Injuries (Trauma)
01/2011 - 11/2008
1
Glucose Intolerance
09/2022
1
Body Weight Changes
07/2022
1
Necrosis
03/2022
1
Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022
1
Autoimmune Hepatitis
01/2022
1
Inflammation (Inflammations)
10/2021
1
Alcoholic Fatty Liver
10/2021
Drug/Important Bio-Agent (IBA)
48
Antiviral Agents (Antivirals)
IBA
09/2022 - 02/2011
23
Ribavirin (Virazole)
FDA Link
Generic
01/2022 - 08/2010
22
Interferons
IBA
01/2022 - 08/2010
17
RNA (Ribonucleic Acid)
IBA
01/2022 - 05/2015
13
Hepatitis B Surface Antigens (HBsAg)
FDA Link
12/2021 - 01/2011
8
Biomarkers (Surrogate Marker)
IBA
04/2022 - 08/2010
8
Proteins (Proteins, Gene)
FDA Link
03/2022 - 05/2011
8
Alanine Transaminase (SGPT)
IBA
12/2021 - 05/2015
8
DNA (Deoxyribonucleic Acid)
IBA
12/2021 - 01/2011
6
Glucose (Dextrose)
FDA Link
Generic
09/2022 - 04/2009
6
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
01/2022 - 02/2015
5
Sorafenib (BAY 43-9006)
FDA Link
02/2022 - 10/2019
5
mica
IBA
01/2019 - 12/2015
4
Hepatitis B e Antigens
IBA
07/2022 - 04/2014
4
Tenofovir (Viread)
FDA Link
07/2022 - 01/2020
4
Carrier Proteins (Binding Protein)
IBA
03/2022 - 08/2017
4
entecavir
FDA Link
02/2022 - 11/2016
4
Pharmaceutical Preparations
IBA
02/2022 - 01/2014
4
Cytokines
IBA
01/2022 - 03/2011
4
nas
IBA
10/2021 - 01/2019
4
Uric Acid (Urate)
IBA
03/2020 - 01/2015
4
Fetal Proteins (Fetoprotein)
IBA
01/2020 - 03/2015
3
wisteria lectin
IBA
03/2022 - 08/2017
3
Sofosbuvir
IBA
02/2022 - 01/2021
3
Bilirubin
IBA
01/2022 - 10/2019
3
Interferon-alpha (Interferon Alfa)
IBA
04/2021 - 01/2015
3
Antigens
IBA
04/2021 - 11/2016
3
Nucleosides
IBA
01/2021 - 11/2020
3
Nucleotides
IBA
01/2021 - 11/2020
3
Lipids
IBA
11/2020 - 05/2015
3
Phospholipases (Phospholipase)
IBA
03/2016 - 03/2015
2
Autoantibodies
IBA
01/2022 - 06/2012
2
Transaminases (Aminotransferases)
IBA
12/2021 - 01/2020
2
Insulin (Novolin)
FDA Link
10/2021 - 05/2015
2
Albumins
IBA
04/2021 - 01/2020
2
Indicators and Reagents (Reagents)
IBA
01/2021 - 02/2019
2
asunaprevir
IBA
01/2021 - 01/2020
2
daclatasvir
IBA
01/2021 - 01/2020
2
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
01/2021 - 01/2017
2
Interleukins
IBA
03/2018 - 04/2013
2
Peptides (Polypeptides)
IBA
05/2017 - 12/2015
2
Hemoglobins (Hemoglobin)
IBA
04/2017 - 04/2008
2
Lamivudine (Epivir)
FDA Link
11/2016 - 04/2016
2
MicroRNAs (MicroRNA)
IBA
03/2016 - 05/2014
1
sofosbuvir drug combination ledipasvir
IBA
08/2022
1
tenofovir alafenamide
IBA
07/2022
1
Collagen
IBA
07/2022
1
Anti-Bacterial Agents (Antibiotics)
IBA
03/2022
1
velpatasvir
IBA
02/2022
1
Chemokines
IBA
01/2022
1
regorafenib
IBA
01/2022
1
L 644711 (B-3(+))
IBA
10/2021
Therapy/Procedure
52
Therapeutics
04/2022 - 08/2010
4
Renal Dialysis (Hemodialysis)
08/2021 - 01/2014
4
Liver Transplantation
06/2018 - 01/2013
2
Debridement
03/2022 - 03/2002
2
Laparotomy
09/2018 - 10/2017
2
Operative Surgical Procedures
09/2018 - 09/2006
2
Secondary Prevention
06/2017 - 12/2015
1
Colostomy
03/2022
1
Drug Therapy (Chemotherapy)
02/2022
1
Salvage Therapy
01/2022